MedTrace Logo

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

NCT06953180 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6720

Last updated 2025-07-11

No results posted yet for this study

Summary

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Conditions

  • Cardiovascular Diseases (CVD)
  • Type 2 Diabetes
  • Chronic Respiratory Diseases
  • Obesity (Disorder)
  • Chronic Kidney Diseases

Interventions

OTHER

Genetic: DNA analysis

Investigation of telomere length (TL) and DNA methylation level analysis

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-03
Primary Completion
2026-01-01
Completion
2026-12-31

Countries

  • Kazakhstan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06953180 on ClinicalTrials.gov